Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the arthritis monoclonal antibodies market size evolved in recent years?

The market for arthritis monoclonal antibodies has seen robust growth in recent years. The market which was worth $58.09 billion in 2024 is projected to rise to $62.29 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.2%. The impressive growth during the previous years is linked to factors such as the escalating incidence of arthritis, enhanced understanding of arthritis monoclonal antibodies, the expansion of approved monoclonal antibodies for arthritis, governmental backing for research and development along with amplified investments from pharma corporations.

What are the predictions for the arthritis monoclonal antibodies market size in the coming years?

In the coming years, a robust growth is expected in the arthritis monoclonal antibodies market, with its size expected to reach $83.76 billion in 2029, representing a compound annual growth rate (CAGR) of 7.7%. The anticipated growth can be linked to an increase in combination therapies, broader implications, patient choice, and elevated healthcare expenditure. Key trends set to shape the forecast period include biosimilars and biobetters, targeted treatments, home-based care, real-world data, concerns related to cost and access, and developments in drug delivery.

Get your arthritis monoclonal antibodies market report here!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3449&type=smp

What key factors are fueling the growth of the arthritis monoclonal antibodies market?

The global rise in arthritis cases is notably fuelling the expansion of the arthritis monoclonal antibody market. The Global RA Network highlighted in 2021 that arthritis and osteoarthritis affect over 350 million people across the world. Osteoarthritis emerges as the most prevalent form, with gout, fibromyalgia, and rheumatoid arthritis trailing behind. Projection from Arthritis Australia, a non-profit charitable entity, in February 2024 shows that the Australian arthritis population is set to surge from 4.11 million in 2025 to 5.39 million in 2040. This upsurge in arthritis cases is, therefore, a significant propellant for the arthritis monoclonal antibody market’s growth.

How is the global arthritis monoclonal antibodies market divided into key segments?

The arthritis monoclonal antibodies market covered in this report is segmented –

1) By Drug: Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia, Remsima

2) By Application: Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Other Applications

3) By End-Use: Hospitals, Research Institutes, Other End-Users

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3449&type=smp

Who are the key firms paving the way for growth in the arthritis monoclonal antibodies market?

Major companies operating in the arthritis monoclonal antibodies market include Johnson & Johnson, Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., AbbVie Inc., Amgen Inc., Genentech Inc., GlaxoSmithKline plc., AstraZeneca plc, Bristol Myers Squibb, Eli Lilly and Company, Thermo Fisher Scientific Inc., Sanofi SA, Daiichi Sankyo Company Ltd., Seattle Genetics, Teva Pharmaceutical Industries Ltd., Shanghai Junshi Biosciences Co. Ltd., GenScript Biotech Corporation, Sigma-Aldrich Co. LLC, AbGenomics Corp., ADC Therapeutics SA, Agensys Inc., Alexion Pharmaceuticals Inc., ALMAC Group Ltd., Ambrx Inc., Astellas Pharma Inc., Celgene Corporation, Celldex Therapeutics Inc., Boehringer Ingelheim International GmbH, Celltrion Inc., HanAll Biopharma Co. Ltd., Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation, Regeneron Pharmaceuticals Inc., Samsung Bioepis Co. Ltd.

Which trends are expected to transform the arthritis monoclonal antibodies market?

The progress in creating therapeutic monoclonal antibody products is proving to be crucial in advancing the arthritis monoclonal antibody market. Compared to small molecules and peptides, monoclonal antibodies show greater effectiveness in addressing arthritis. They are target-specific and exhibit high performance in disease management. This is highlighted by the increased release of monoclonal antibody drugs for arthritis in the market.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3449

What regions are contributing significantly to the growth of the arthritis monoclonal antibodies market?

North America was the largest region in the arthritis monoclonal antibodies market in 2024. The regions covered in the arthritis monoclonal antibodies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:

Orthobiologics Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/orthobiologics-devices-and-equipment-global-market-report

Interleukin Inhibitors Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/interleukin-inhibitor-global-market-report

Pre Filled Syringes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pre-filled-syringes-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: